IL-4R drives dedifferentiation, mitogenesis, and metastasis in rhabdomyosarcoma

Tohru Hosoyama, Mohammed Imran Aslam, Jinu Abraham, Suresh I. Prajapati, Koichi Nishijo, Joel E. Michalek, Lee Ann Zarzabal, Laura D. Nelon, Denis C. Guttridge, Brian P. Rubin, Charles Keller

Research output: Contribution to journalArticle

36 Scopus citations

Abstract

Purpose: Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in childhood. The alveolar subtype of rhabdomyosarcoma (ARMS) is a paradigm for refractory and incurable solid tumors because more than half of the children at diagnosis have either regional lymph node or distant metastases. These studies follow our previous observation that Interleukin-4 receptor α (IL-4Rα) is upregulated in both human and murine ARMS, and that the IL-4R signaling pathway may be a target for abrogating tumor progression. Experimental Design: By in vitro biochemical and cell biology studies as well as preclinical studies using a genetically engineered mouse model, we evaluated the role of IL-4 and IL-13 in IL-4R-mediated mitogenesis, myodifferentiation, and tumor progression. Results: IL-4 and IL-13 ligands accelerated tumor cell growth and activated STAT6, Akt, or MAPK signaling pathways in the human RMS cell lines, RD and Rh30, as well as in mouse primary ARMS cell cultures. IL-4 and IL-13 treatment also decreased protein expression of myogenic differentiation factors MyoD and Myogenin, indicating a loss of muscle differentiation. Using a genetically engineered mouse model of ARMS, we have shown that inhibition of IL-4R signaling pathway with a neutralizing antibody has a profound effect on the frequency of lymph node and pulmonary metastases, resulting in significant survival extension in vivo. Conclusions: Our results indicate that an IL-4R-dependent signaling pathway regulates tumor cell progression in RMS, and inhibition of this pathway could be a promising adjuvant therapeutic approach.

Original languageEnglish (US)
Pages (from-to)2757-2766
Number of pages10
JournalClinical Cancer Research
Volume17
Issue number9
DOIs
StatePublished - May 1 2011

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'IL-4R drives dedifferentiation, mitogenesis, and metastasis in rhabdomyosarcoma'. Together they form a unique fingerprint.

  • Cite this

    Hosoyama, T., Aslam, M. I., Abraham, J., Prajapati, S. I., Nishijo, K., Michalek, J. E., Zarzabal, L. A., Nelon, L. D., Guttridge, D. C., Rubin, B. P., & Keller, C. (2011). IL-4R drives dedifferentiation, mitogenesis, and metastasis in rhabdomyosarcoma. Clinical Cancer Research, 17(9), 2757-2766. https://doi.org/10.1158/1078-0432.CCR-10-3445